Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) FCF Margin (2016 - 2025)

Historic FCF Margin for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to 2.41%.

  • Usana Health Sciences' FCF Margin fell 159700.0% to 2.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.05%, marking a year-over-year decrease of 55700.0%. This contributed to the annual value of 5.96% for FY2024, which is 1400.0% down from last year.
  • Latest data reveals that Usana Health Sciences reported FCF Margin of 2.41% as of Q3 2025, which was down 159700.0% from 3.05% recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' FCF Margin ranged from a high of 16.31% in Q4 2022 and a low of 2.41% during Q3 2025
  • Moreover, its 5-year median value for FCF Margin was 5.08% (2025), whereas its average is 6.02%.
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 136600bps in 2022, then crashed by -159700bps in 2025.
  • Usana Health Sciences' FCF Margin (Quarter) stood at 5.86% in 2021, then skyrocketed by 178bps to 16.31% in 2022, then tumbled by -48bps to 8.46% in 2023, then plummeted by -78bps to 1.86% in 2024, then plummeted by -229bps to 2.41% in 2025.
  • Its last three reported values are 2.41% in Q3 2025, 3.05% for Q2 2025, and 5.08% during Q1 2025.